Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_assertion type Assertion NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_head.
- NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_assertion description "[To analyze the immunotherapeutic potentials of genetically engineered tumor cells secreting IL-2 and a membrane-expressing allogeneic MHC class I molecule Kb in a murine hepatoma model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_provenance.
- NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_assertion evidence source_evidence_literature NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_provenance.
- NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_assertion SIO_000772 11206268 NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_provenance.
- NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_assertion wasDerivedFrom befree-20140225 NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_provenance.
- NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_assertion wasGeneratedBy ECO_0000203 NP422873.RAs1PTRDRw6gUFArA9PheRawKeEoGV7BznPaC31Vq7iT0130_provenance.